Zheng QN, Xu MY, Gan FM, Ye SS, Zhao H. Thymosin as a possible therapeutic drug for COVID-19: a case report. World J Clin Cases. 2021;9(16):4090–4.

Article  PubMed  PubMed Central  Google Scholar 

Luo XH, Zhu Y, Mao J, Du RC. T cell immunobiology and cytokine storm of COVID-19. Scand J Immunol. 2021;93(3):e12989.

Article  CAS  PubMed  Google Scholar 

Yu Y, Tian JH, Yang KH, Zhang P. [Evaluation of efficacy of thymosin alpha1 in the treatment of sepsis: a systematic review]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21(1):21–4.

CAS  PubMed  Google Scholar 

Huang C, Fei L, Xu W, Li W, Xie X, Li Q, Chen L. Efficacy evaluation of Thymosin alpha 1 in non-severe patients with COVID-19: a retrospective cohort study based on propensity score matching. Front Med (Lausanne). 2021;8:664776.

Article  PubMed  Google Scholar 

Shetty A, Chandrakant NS, Darnule RA, Manjunath BG, Sathe P. A double-blind multicenter two-arm randomized placebo-controlled phase-III clinical study to evaluate the effectiveness and safety of thymosin α1 as an add-on treatment to existing standard of care treatment in moderate-to-severe COVID-19 patients. Indian J Crit Care Med. 2022;26(8):913–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goronzy JJ, Fang F, Cavanagh MM, Qi Q. Weyand CM Naïve T cell maintenance and function in human aging. J Immunol. 2015;194(9):4073–80.

Article  CAS  PubMed  Google Scholar 

Bersanelli M, Giannarelli D, Leonetti A, Buti S, Tiseo M, Nouvenne A, Ticinesi A, Meschi T, Procopio G, Danielli R. The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients. Future Oncol. 2021;17(9):1097–104.

Article  CAS  PubMed  Google Scholar 

Liu Y, Pan Y, Hu Z, Wu M, Wang C, Feng Z, Mao C, Tan Y, Liu Y, Chen L, Li M, Wang G, Yuan Z, Diao B, Wu Y, Chen Y. Thymosin alpha 1 reduces the mortality of severe coronavirus disease 2019 by restoration of lymphocytopenia and reversion of exhausted T cells. Clin Infect Dis. 2020;71(16):2150–7.

Article  CAS  PubMed  Google Scholar 

Lins MP, Smaniotto S. Potential impact of SARS-CoV-2 infection on the thymus. Can J Microbiol. 2021;67(1):23–8.

Article  CAS  PubMed  Google Scholar 

Li M, Guo W, Dong Y, Wang X, Dai D, Liu X, Wu Y, Li M, Zhang W, Zhou H, Zhang Z, Lin L, Kang Z, Yu T, Tian C, Qin R, Gui Y, Jiang F, Fan H, Heissmeyer V, Sarapultsev A, Wang L, Luo S, Hu D. Elevated exhaustion levels of NK and CD8+ T cells as indicators for progression and prognosis of COVID-19 disease. Front Immunol. 2020;11:580237.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu K, He J, Wu Y, Xie B, Liu X, Wei B, et al. Dysregulated adaptive immune response contributes to severe COVID-19. Cell Res. 2020;30(9):814–6.

Article  CAS  PubMed  Google Scholar 

Matteucci C, Minutolo A, Balestrieri E, Petrone V, Fanelli M, Malagnino V, et al. Thymosin alpha 1 mitigates cytokine storm in blood cells from coronavirus disease 2019 patients. Open Forum Infect Dis. 2021;8(1):ofaa588.

Article  PubMed  Google Scholar 

Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92(5):479–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ricci D, Etna MP, Severa M, Fiore S, Rizzo F, Iannetta M, Andreoni M, Balducci S, Stefanelli P, Palamara AT, Coccia EM. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model. Int Immunopharmacol. 2023;117:109996.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu R, Mao Y, Li K, Zhai Y, Zhang Y, Liu S, Gao Y, Chen Z, Liu Y, Fang T, Zhao M, Li R, Xu J, Chen W. Recombinant human Thymosin Beta-4 protects against mouse coronavirus infection. Mediators Inflamm. 2021;2021:9979032.

Article  PubMed  PubMed Central  Google Scholar 

Sun Q, Xie J, Zheng R, Li X, Chen H, Tong Z, Du B, Qiu H, Yang Y. The effect of thymosin α1 on mortality of critical COVID-19 patients: a multicenter retrospective study. Int Immunopharmacol. 2021;90:107143.

Article  CAS  PubMed  Google Scholar 

Shang W, Zhang B, Ren Y, Wang W, Zhou D, Li Y. Thymosin alpha1 use in adult COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Int Immunopharmacol. 2023;114:109584.

Article  CAS  PubMed  Google Scholar 

Liu T, Liu S, Li T, Zhang J. Thymosin a1 use is not associated with reduced COVID-19 mortality. Am J Emerg Med. 2022;53:252–3.

Article  PubMed  Google Scholar 

Wu M, Ji JJ, Zhong L, Shao ZY, Xie QF, Liu ZY, Wang CL, Su L, Feng YW, Liu ZF, Yao YM. Thymosin α1 therapy in critically ill patients with COVID-19: a multicenter retrospective cohort study. Int Immunopharmacol. 2020;88:106873.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuthill CW, Awad A, Parrigon M, Ershler WB. A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: preliminary report. Int Immunopharmacol. 2023;117:109950.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ancell CD, Phipps J, Young L. Thymosin alpha-1. Am J Health Syst Pharm. 2001;58(10):879–85. quiz 886-8.

Article  CAS  PubMed  Google Scholar 

Dominari A, Hathaway Iii D, Pandav K, Matos W, Biswas S, Reddy G, Thevuthasan S, Khan MA, Mathew A, Makkar SS, Zaidi M, Fahem MMM, Beas R, Castaneda V, Paul T, Halpern J, Baralt D. Thymosin alpha 1: a comprehensive review of the literature. World J Virol. 2020;9(5):67–78.

Article  PubMed  PubMed Central  Google Scholar 

Bellet MM, Renga G, Pariano M, Stincardini C, D’Onofrio F, Goldstein AL, Garaci E, Romani L, Costantini C. COVID-19 and beyond: reassessing the role of thymosin alpha1 in lung infections. Int Immunopharmacol. 2023;117:109949.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang T, Lin Q, Xie Y, Yang L, Cao S, Dong H, Du J, Wang R. [Thymosin alpha 1 for the adjuvant treatment of coronavirus disease 2019: a retrospective cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022;34(5):497–501.

PubMed  Google Scholar